THE FACT ABOUT KINASE INHIBITOR-1 THAT NO ONE IS SUGGESTING

The phylogenetic map of the human kinome demonstrating growth and US FDA acceptance of compact molecule kinase inhibitors to tyrosine kinases and serine/threonine kinases for many different stable and hematologic malignancies.The magnificent success demonstrated with imatinib mesylate (aka Gleevec) focusing on crack stage cluster (Bcr)-Abelson (Abl